Retrospective Analysis of 32 Pediatric Patients with Anticonvulsant Hypersensitivity Syndrome (ACHSS)

Abstract:  Objectıve:  To review 32 pediatric patients with anticonvulsant hypersensitivity syndrome.

[1]  A. Baptist,et al.  Anticonvulsant hypersensitivity syndrome: Is there a role for immunomodulation? , 2008, Epilepsia.

[2]  D. Metry,et al.  Use of intravenous immunoglobulin in children with stevens-johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature. , 2003, Pediatrics.

[3]  M. Karakaş,et al.  The anticonvulsant hypersensitivity syndrome , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  M. Contin,et al.  Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitone. , 2003, Clinical neuropharmacology.

[5]  K. Harman,et al.  Persistent anticonvulsant hypersensitivity syndrome responding to ciclosporin , 2003, Clinical and experimental dermatology.

[6]  S. Taş,et al.  Management of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS Syndrome): An Update , 2003, Dermatology.

[7]  K. Doh,et al.  Clinicopathological and genotypic aspects of anticonvulsant‐induced pseudolymphoma syndrome , 2003, The British journal of dermatology.

[8]  V. Descamps,et al.  Prodynorphin gene promoter polymorphism and temporal lobe epilepsy , 2003, Annals of neurology.

[9]  Tatsuo Yamada,et al.  Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome , 2002, Annals of neurology.

[10]  T. Pham,et al.  Antiepileptic hypersensitivity syndrome: Clinicians beware and be aware , 2002, Current allergy and asthma reports.

[11]  N. Esterly,et al.  Drug-induced hypersensitivity syndrome in pediatric patients. , 2001, Pediatrics.

[12]  R. Hatton,et al.  Antiepileptic Hypersensitivity Syndrome in Children , 2001, The Annals of pharmacotherapy.

[13]  T. Lachgar,et al.  [The drug hypersensitivity syndrome or DRESS syndrome to phenobarbital]. , 2001, Allergie et immunologie.

[14]  L. Liao,et al.  Possible Atypical Cross‐Sensitivity between Phenytoin and Carbamazepine in the Anticonvulsant Hypersensitivity Syndrome , 2001, Pharmacotherapy.

[15]  S. Ashkenazi,et al.  Successful treatment of antiepileptic drug hypersensitivity syndrome with intravenous immune globulin. , 2001, Pediatrics.

[16]  U. Tröger,et al.  Development of a pulmonary phenytoin-associated hypersensitivity reaction despite concomitant dexamethasone and prednisolone administration. , 2000, International journal of clinical pharmacology and therapeutics.

[17]  H. Tabenkin,et al.  [Carbamazepine hypersensitivity symptoms]. , 2000, Harefuah.

[18]  B. M. Sarris,et al.  Multisystem hypersensitivity reaction to lamotrigine , 1999, Neurology.

[19]  L. Naldi,et al.  Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study , 1999, The Lancet.

[20]  M. Rudis,et al.  Cross-sensitivity and the anticonvulsant hypersensitivity syndrome. , 1999, The Journal of emergency medicine.

[21]  E. Mylonakis,et al.  Lamotrigine Overdose Presenting as Anticonvulsant Hypersensitivity Syndrome , 1999, The Annals of pharmacotherapy.

[22]  H. Hamer,et al.  Successful treatment with gabapentin in the presence of hypersensitivity syndrome to phenytoin and carbamazepine: a report of three cases , 1999, Seizure.

[23]  P. Rudge.  Are clinical trials of therapeutic agents for MS long enough? , 1999, The Lancet.

[24]  R. Stern,et al.  Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. , 1999, Lancet.

[25]  J. Callen,et al.  Hypersensitivity Reaction in a Child Due to Lamotrigine , 1999, Pediatric dermatology.

[26]  J. Tschopp,et al.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. , 1998, Science.

[27]  Lewis,et al.  Lamotrigine and phenobarbitone‐associated hypersensitivity syndrome: resolution without corticosteroids , 1998, The British journal of dermatology.

[28]  D. Descamps,et al.  Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome , 1997, The British journal of dermatology.

[29]  R. Goel,et al.  Phenytoin hypersensitivity syndrome. , 1997, Indian journal of dermatology, venereology and leprology.

[30]  N. Frangogiannis,et al.  Cyclophosphamide in the treatment of toxic epidermal necrolysis. , 1996, Southern medical journal.

[31]  N. Levell,et al.  Systemic corticosteroids in the phenytoin hypersensitivity syndrome , 1996, The British journal of dermatology.

[32]  W. Grabski,et al.  Dilantin hypersensitivity reaction. , 1996, Cutis.

[33]  J. Muglia,et al.  Anticonvulsant hypersensitivity syndrome. , 1995, Archives of internal medicine.

[34]  A. D. De Vriese,et al.  Carbamazepine Hypersensitivity Syndrome: Report of 4 Cases and Review of the Literature , 1995, Medicine.

[35]  R. Bertz,et al.  Diazepam by Continuous Intravenous Infusion for Status Epilepticus in Anticonvulsant Hypersensitivity Syndrome , 1993, The Annals of pharmacotherapy.

[36]  M. Rieder,et al.  Drug‐induced hypothyroidism: The thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides , 1992, Clinical pharmacology and therapeutics.

[37]  S. Spielberg,et al.  Familial occurrence of hypersensitivity to phenytoin. , 1991, The American journal of medicine.

[38]  S. Allen,et al.  Efficacy of cyclophosphamide in toxic epidermal necrolysis. Clinical and pathophysiologic aspects. , 1991, Journal of the American Academy of Dermatology.

[39]  M. Dunn,et al.  Phenytoin Hypersensitivity Syndrome: A Case Report , 1991, DICP : the annals of pharmacotherapy.

[40]  D. Breneman,et al.  Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. , 1991, Archives of dermatology.

[41]  S. Spielberg,et al.  Phenobarbital hepatotoxicity in an 8-month-old infant. , 1990, Journal of hepatology.

[42]  R. Stern,et al.  The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. , 1990 .

[43]  M. Warnock,et al.  Massive hepatic necrosis in a child after administration of phenobarbital. , 1989, The American journal of gastroenterology.

[44]  Black Dm,et al.  Case report of antiepileptic drug hypersensitivity reaction: pseudolymphoma syndrome. , 1989 .

[45]  D. Fivenson,et al.  Case report of antiepileptic drug hypersensitivity reaction: pseudolymphoma syndrome. , 1989, Family practice research journal.

[46]  S. Spielberg,et al.  Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. , 1988, The Journal of clinical investigation.

[47]  F. Flowers,et al.  Phenytoin hypersensitivity syndrome. , 1987, The Journal of emergency medicine.

[48]  J. Engel,et al.  Phenytoin hypersensitivity: a case of severe acute rhabdomyolysis. , 1986, The American journal of medicine.

[49]  T. Schubert,et al.  Phenytoin hypersensitivity hepatitis and mononucleosis syndrome. , 1986, Journal of clinical gastroenterology.

[50]  G. Lazarus,et al.  Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy". , 1985, Journal of the American Academy of Dermatology.

[51]  G. Faguet,et al.  Drug-induced liver injury. In vitro demonstration of hypersensitivity to both phenytoin and phenobarbital. , 1984, Archives of internal medicine.

[52]  R. Tomsick.  The phenytoin syndrome. , 1983, Cutis.

[53]  M. Glasberg,et al.  Myopathy and hypersensitivity to phenytoin , 1983, Neurology.

[54]  E. Mellits,et al.  Anticonvulsant toxicity in vitro: possible role of arene oxides. , 1981, The Journal of pharmacology and experimental therapeutics.